AntiCan Cancer Research Results
AntiCan, Anticancer Effect: Click to Expand ⟱
| Source: |
| Type: general indicator |
Anticancer Effect
|
Liver, Liver Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vivo, |
Liver, |
HepG2 |
|
|
|
- |
NA, |
Nor, |
NA |
|
|
|
*hepatoP↑, AntiCan↑,
AntiCan↑, Apoptosis↑, TumCP↓, EMT↓, Imm↑, ChemoSen↑, BioAv↓, TumCG↓, IL2↑, IL12↑, TNF-α↑, P-gp↓, MDR1↓, QoL↑, Casp↑, DNAdam↑, Bcl-2↓, BAX↑, MMP↓, Cyt‑c↑, NOTCH1↓, GSK‐3β↓, TumCCA↑, GSH↓, ROS↑, lipid-P↑, c-Iron↑, GPx4↓, ACSL4↑, Ferroptosis↑, Wnt↓, β-catenin/ZEB1↓, cycD1/CCND1↓, Akt↓, PI3K↓, mTOR↓, CXCR4↓, Vim↓, PD-L1↓, eff↑, eff↑, ChemoSen↑, ChemoSen↑, chemoP↑,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
Diabetic, |
NA |
|
|
|
AntiCan↑, Dose↝, *antiOx↑, *AntiDiabetic↑, *Bacteria↓,
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
*Bacteria↓, tumCV↓, selectivity↑, ROS↑, Apoptosis↑, TumCMig↓, AntiCan↑,
tumCV↓, AntiCan↑, P53↑, Bcl-2↓,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
CRC, |
COLO205 |
|
|
|
AntiCan↑, Apoptosis↑, selectivity↑, Ca+2↑, Cyt‑c↑, Casp3↑, Casp8↑, Casp9↑, Bcl-2↓,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vivo, |
CRC, |
COLO205 |
|
|
|
AntiCan↑, selectivity↑, TumCCA↑, P21↑, Apoptosis↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
Dose↝, AntiCan↑, eff↑,
Showing Research Papers: 1 to 8 of 8
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Ferroptosis↑, 1, GPx4↓, 1, GSH↓, 1, c-Iron↑, 1, lipid-P↑, 1, ROS↑, 2,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
ACSL4↑, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 4, BAX↑, 1, Bcl-2↓, 3, Casp↑, 1, Casp3↑, 1, Casp8↑, 1, Casp9↑, 1, Cyt‑c↑, 2, Ferroptosis↑, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 2,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, P21↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, GSK‐3β↓, 1, mTOR↓, 1, NOTCH1↓, 1, PI3K↓, 1, TumCG↓, 1, Wnt↓, 1,
Migration ⓘ
Ca+2↑, 1, TumCMig↓, 1, TumCP↓, 1, Vim↓, 1, β-catenin/ZEB1↓, 1,
Barriers & Transport ⓘ
P-gp↓, 1,
Immune & Inflammatory Signaling ⓘ
CXCR4↓, 1, IL12↑, 1, IL2↑, 1, Imm↑, 1, PD-L1↓, 1, TNF-α↑, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, ChemoSen↑, 3, Dose↝, 2, eff↑, 3, MDR1↓, 1, selectivity↑, 3,
Clinical Biomarkers ⓘ
PD-L1↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 8, chemoP↑, 1, QoL↑, 1,
Total Targets: 53
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1,
Functional Outcomes ⓘ
AntiDiabetic↑, 1, hepatoP↑, 1,
Infection & Microbiome ⓘ
Bacteria↓, 2,
Total Targets: 4
Scientific Paper Hit Count for: AntiCan, Anticancer Effect
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:14 Cells:% prod#:% Target#:813 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page